Alzamend Neuro, Inc. - stock earnings
ALZN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -5.4 million USD | ? USD |
| 2022Q4 | -3.1 million USD | ? USD |
| 2022Q3 | -3.0 million USD | ? USD |
| 2022Q2 | -3.9 million USD | ? USD |
| 2022Q1 | -2.6 million USD | ? USD |
| 2021Q4 | -3.6 million USD | ? USD |
| 2021Q3 | -2.3 million USD | ? USD |
| 2021Q2 | -1.3 million USD | ? USD |
| 2020Q4 | -1.4 million USD | ? USD |
ALZN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -14.9 million USD | ? USD |
| 2022 | -12.4 million USD | ? USD |
| 2021 | -5.2 million USD | ? USD |
| 2020 | -4.4 million USD | ? USD |
| 2019 | -4.9 million USD | ? USD |
| 2018 | -931663 USD | ? USD |
ALZN
Price: $0.71
52 week price:
Earnings Per Share: -1.78 USD
P/E Ratio: -0.38
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 216306
Market Capitalization: 6.3 million